市场调查报告书
商品编码
1380434
2023-2030 年全球自动显微镜市场Global Automated Microscopy Market 2023-2030 |
全球自动化显微镜市场预计在预测期内(2023-2030)将以 7.5% 的CAGR成长。市场的成长归功于扫描电子显微镜(SEM)技术的发展。自动化功能的发展,包括「简单SEM」摄影、剪辑和即时元素分析,显示扫描电子显微镜技术不断进步。为研究和应用寻求更有效、更方便的工具的使用者被上述增强功能所吸引。例如,2022 年 1 月,JEOL 推出了具有「简单 SEM」自动化和即时元素和 3D 分析功能的新型扫描电子显微镜。新型扫描电子显微镜具有提高生产力的自动化功能,例如「简单 SEM」自动成像、自动拼接(影像和 EDS 图)以及即时 EDS 分析(光谱和图)。
全球自动化显微镜市场按产品、应用和最终用户进行细分。依产品,市场细分为倒置显微镜、萤光显微镜、电子显微镜、扫描电子显微镜、光学显微镜等。根据应用,市场分为生命科学和生物医学研究半导体等。此外,根据最终用户,市场细分为医院和医疗机构、学术和研究机构、临床和诊断实验室等。在该产品中,光学显微镜子类别预计将占据很大一部分市场份额。与电子显微镜或扫描探针显微镜等其他显微镜方法相比,光学显微镜更容易使用且更具成本效益。
在最终用户中,临床和诊断实验室细分市场预计将在全球自动显微镜市场中占据相当大的份额。该细分市场的成长归因于对诊断和临床实验室的需求不断增长。为了帮助疾病诊断、患者治疗和监测,临床和诊断实验室进行各种测试。 UNIQO 160主要满足这些实验室在自体免疫疾病诊断上的需求。例如,2023年6月,Revvity Inc.推出了UNIQO 160(CE-IVDR),这是一种用于自体免疫疾病诊断的自动化间接免疫萤光测试(IIFT)系统。整合解决方案提高了整个 IIFT 程序的效率,包括样品製备、孵育、清洗和载玻片安装以及影像撷取和分析。
全球自动化显微镜市场根据地理位置进一步细分,包括北美(美国和加拿大)、欧洲(英国、义大利、西班牙、德国、法国和欧洲其他地区)、亚太地区(印度、中国、日本) 、韩国和亚洲其他地区)以及世界其他地区(中东和非洲以及拉丁美洲)。其中,由于亚太地区有利的经济环境和丰富的潜在客户,预计该地区将在全球市场中占据显着份额。此外,许多重要的自动化显微镜企业正在扩大其业务,预计这将进一步加速市场扩张。
在所有地区中,预计北美在预测期内将以相当大的CAGR成长。区域增长归因于该地区结核病 (TB) 诊断和治疗的增加。作为一个重大的全球健康问题,结核病需要及时发现和治疗,这需要有效的诊断技术。 μ-Scan 2.0 增强的敏感度和特异度可改善结核病的控制和管理。据美国国立卫生研究院(NIH.gov)称,2022年5月,μ-Scan 2.0自动化系统在一项涉及1726张涂片的多中心、双盲试验中进行了评估。此系统的准确率为95.7%,敏感性为87.7%(57/65),特异性为96.0%(1,594/1,661)。盛行率为 8.2% 时,阴性预测值为 97.8%。 μ-Scan 2.0自动化系统被发现比手动涂片显微镜具有更高的结核涂片灵敏度和实验室效率,并为结核病诊断和控制提供了具有成本效益的解决方案。它还可以透过网路连线远端使用,适合医疗资源有限的地区。
服务全球自动显微镜市场的主要公司包括:日立高新技术公司、Holmoc Opto-Mechatronics Ltd.、JEOL Ltd.、Keyence Corp.、Leica Microsystems 等。市场参与者透过各种策略(包括併购、合作、合作、融资和新产品发布),为市场成长做出了巨大贡献,以保持市场竞争力。例如,2023 年 5 月,HORIBA 推出了 EasyImage,这是一种用于拉曼显微镜的新型成像工具。 EasyImage 旨在帮助新用户快速产生可发布的结果。它提供了使用拉曼光谱生成化学图像、聚焦和选择感兴趣区域、优化成像参数、选择光谱指纹、预览测量结果和收集高品质化学图像的 5 个关键步骤的指导。
Title: Global Automated Microscopy Market Size, Share & Trends Analysis Report by Product (Inverted Microscope, Fluorescence Microscope, Electron Microscope, Scanning Electron Microscopes (SEM), Optical Microscope, and Others), by Application (Life Sciences and Biomedical Research, Semiconductors, and Others), and by End-User (Hospitals and Healthcare Facilities, Academic and Research Institutions, Clinical and Diagnostic Laboratories, and Others)Forecast Period (2023-2030).
The global automated microscopy market is anticipated to grow at a CAGR of 7.5% during the Forecast Period (2023-2030). The market's growth is attributed to the development in scanning electron microscope (SEM) technology. The development of automation features, including "Simple SEM" photography, montaging, and live elemental analysis, indicates that scanning electron microscopy technology constantly progressing. Users seeking more effective and convenient tools for their research and applications are attracted by the aforementioned enhancements. For instance, in January 2022, JEOL Introduced new Scanning Electron Microscope with "Simple SEM" Automation and Live Elemental And 3D Analysis. The new scanning electron microscope has productivity-enhancing automation, such as "Simple SEM" automated imaging, automated montaging (both image and EDS map),and live EDS analysis (spectrum and map).
The global automated microscopy market is segmented on the products, applications, and end-users. Based on the product, the market is sub-segmented into inverted microscope, fluorescence microscope, electron microscope, scanning electron microscopes, optical microscope, and others. Based on the applications, the market is sub-segmented into life sciences and biomedical research semiconductors, and others. Furthermore, based on end-user, the market is sub-segmented into hospitals and healthcare facilities, academic and research institutions, clinical and diagnostic laboratories, and others. Among the product, the optical microscope sub-category is expected to capture a significant portion of the market share. Optical microscopes are more accessible and cost-effective compared to other microscopy methods such as electron microscopy or scanning probe microscopy.
Among the end-user, the clinical and diagnostic laboratories sub-segment is expected to hold a considerable share of the global Automated Microscopy market. The segmental growth is attributed to growing demand for diagnostic and clinical laboratories. In order to help with disease diagnosis, patient treatment, and monitoring, clinical and diagnostic laboratories perform a variety of tests. The UNIQO 160 primarily addresses the needs of these labs with regard to the diagnosis of autoimmune diseases. For instance, in June 2023, Revvity Inc. launched the UNIQO 160 (CE-IVDR), an automated indirect immunofluorescence test (IIFT) system for autoimmune disease diagnostics. The efficiency of the entire IIFT procedure that includes sample preparation, incubation, washing and mounting of slides, in addition to image acquisition and analysis is increased by the integrated solution.
The global automated microscopy market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, the Asia-Pacific region is anticipated to hold a prominent share of the market globally, owing to the favorable economic environment and abundance of potential clients in the region. Further, number of significant automated microscopy businesses are expanding their operations, which is further anticipated to accelerate market expansion.
Among all regions, North America is anticipated to grow at a considerable CAGR over the forecast period. Regional growth is attributed to the rising tuberculosis (TB) diagnosis and treatment across the region. As a significant global health concern, TB requires prompt detection and treatment, that prompts for effective diagnostic techniques. The enhanced sensitivity and specificity of the μ-Scan 2.0 lead to improved control and management of tuberculosis. According to the National Institute of Health (NIH.gov), in May 2022, the μ-Scan 2.0 automation system was evaluated in a multi-center, double-blind trial involving 1726 smears. The accuracy of the system was 95.7%, the sensitivity was 87.7% (57/65), and the specificity was 96.0% (1,594/1,661). The negative predictive value was 97.8% at a prevalence of 8.2%. The μ-Scan 2.0 automation system was found to have higher TB smear sensitivity and laboratory efficiency than manual smear microscopy, and provides a cost effective solution for TB diagnosis and control. It can also be used remotely through an internet connection, making it suitable for areas with limited medical resources.
The major companies serving the global automated microscopy market include: Hitachi High-Tech Corp., Holmarc Opto-Mechatronics Ltd., JEOL Ltd., Keyence Corp., Leica Microsystems, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in May 2023, HORIBA launched EasyImage, a new imaging tool for Raman microscopy. EasyImage is designed to help new users to quickly generate publication-ready results. It provides guidance on the 5 key steps for generating chemical images using Raman spectroscopy, focusing and selecting an area of interest, optimizing imaging parameters, selecting a spectral fingerprint, previewing measurements, and collecting a high-quality chemical image.